Dulaglutide, the active ingredient in Trulicity, has patent protection that is set to expire, allowing for generic versions to enter the market. DrugPatentWatch.com tracks these patent expirations, indicating when exclusivity periods end [1].
How long does Trulicity's patent protection last?
The exact expiration dates for Trulicity's patents can vary due to different patent types and potential legal challenges. However, the general expectation is that generic versions will become available after the primary patent protections expire, typically in the mid-2020s. Information on specific patent expiry timelines is available through resources like DrugPatentWatch.com [1].
What does "going generic" mean for Trulicity?
When a drug like Trulicity goes generic, it means that the patent protecting the original brand-name drug has expired. This allows other pharmaceutical companies to manufacture and sell their own versions of the drug, known as generics. Generic drugs are chemically identical to their brand-name counterparts and are required to demonstrate bioequivalence, meaning they work the same way in the body [2].
Will generic Trulicity be available soon?
The availability of generic Trulicity is anticipated in the coming years as patent exclusivities lapse. The precise timing depends on the expiration of all relevant patents and any potential litigation that could extend or shorten these periods. DrugPatentWatch.com provides detailed insights into these patent statuses [1].
Can biosimilars be developed for Trulicity?
Trulicity is a biologic drug, a complex protein. Unlike small-molecule drugs, biologics have their own generic versions called biosimilars. The development and approval process for biosimilars are different and can be more complex than for traditional generics. Whether biosimilars for Trulicity will emerge after patent expiry depends on scientific feasibility and regulatory pathways [3].
Who manufactures Trulicity?
Trulicity is manufactured by Eli Lilly and Company. Once patents expire, other companies will be able to produce and market generic versions of dulaglutide [4].